TFC Financial Management
MDGL icon

TFC Financial Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

TFC Financial Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$504 Hold
1
– – ﹤0.01% 758
2026
Q2 		$537 Hold
1
– – ﹤0.01% 749
2026
Q1 		$524 Buy
+1
New +$478 ﹤0.01% 704

Other funds holding MDGL

EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bourgeon Capital Management
Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return
Shikiar Asset Management
Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

TFC Financial Management's MDGL Position: Q3 2026 in Review

TFC Financial Management held its Madrigal Pharmaceuticals (MDGL) position steady in Q3 2026 at 1 share worth $504. The position accounts for ﹤0.01% of the portfolio, ranked #758.

TFC Financial Management first reported a position in MDGL in Q1 2026 and has held it in 3 quarters since. The position peaked at $537 in Q2 2026. 72 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • TFC Financial Management held 1 share of Madrigal Pharmaceuticals worth $504 as of Q3 2026.
  • TFC Financial Management left its Madrigal Pharmaceuticals share count unchanged in Q3 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #758 holding.
  • TFC Financial Management first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • TFC Financial Management's Madrigal Pharmaceuticals position peaked at $537 in Q2 2026.
  • 72 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.